Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
TPX-114 in Full-Thickness Rotator Cuff Tear
NCT03668028Phase 3Completed
- Sponsor
- Tego Science
- Start
- Jul 2018
- Primary completion
- Sep 2021
- Modality
- Adoptive Cell Transfer
- Countries
- 1
01
Overview
A Phase 3 trial of TPX-114 in rotator cuff tear, sponsored by Tego Science. Started Jul 2018; status: completed.
02
Drugs
TPX-114
03
Conditions
rotator cuff tear
Beyond the preview
Go deeper on NCT03668028.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03668028.